Columbia University is launching a new study to determine if a common cancer drug can help slow down ageing in ovaries and delay menopause. The study, called Validating Benefits of Rapamycin for Reproductive Ageing Treatment (Vibrant), will recruit volunteers to take low doses of the drug rapamycin – also a common immunosuppressant used by organ transplant patients.

New study will test if cancer drug can delay ageing in ovaries | Tech News | Metro News


Leave a reply